Home / Taiwan Excellence Award / Award Winning Products / Product Details

NeXgen™ 16HP
Industry type:Health and precision instrument
Product model number:NeXgen 16HP
ZINEXTS LIFE SCIENCE CORP.
award 3

The information related to this product could not be shown due to medical law, please contact the company directly for more information.

https://www.zinexts.com/

Contact online

About ZINEXTS LIFE SCIENCE CORP.

Founded in 2011, Zinexts Life Science Corp. is a leading innovator in in vitro molecular diagnostics, specializing in instruments, reagents, and consumables. With ISO 13485:2016 certification, we uphold the highest standards in medical device manufacturing. Our three facilities in Xizhi received QMS approvals in 2022, 2023, 2024. Guided by our “Safety, Compliance, Customer Focus” policy, we ensure product safety, performance, and regulatory compliance through continuous innovation. Zinexts is Taiwan’s first and the world’s fourth manufacturer certified under ISO 18385:2016 for forensic product manufacturing. We serve over 80 countries with partners in 40+ regions. Beyond core products, Zinexts delivers forensic-grade solutions, AI-integrated qPCR instruments, and proprietary medical reporting systems. Our mission is to provide complete molecular diagnostics solutions- from sample collection to intelligent data interpretation – driving better health and forensic outcomes globally.

https://www.zinexts.com/

Zinexts Life Science Corp. empowers labs with innovative diagnostics developed in Taiwan. Our latest breakthrough, NeXgen? 16HP, is Taiwan’s first fully self-developed, fully automated benchtop multiplex nucleic acid molecular diagnostic system. NeXgen? combines a 16-sample automated extraction module with a 32-well qPCR system supporting multiplex detection across5+ fluorescence channels, delivering precise, actionable results in a single run. Its smart analysis engine interprets multi-target data, generates clear reports, and integrates with LIS/HIS systems. What sets NeXgen? apart is its open platform, compatible with a wide range of commercial or lyophilized PCR reagents, offering unmatched flexibility and cost efficiency. Designed for detecting infectious agents and complex genetic targets, NeXgen? 16 HP launches this November. With NT$400M+ anticipated revenue, it reflects Zinexts’ commitment to global innovation and a healthier world, one test at a time.

Contact info


Other award winning products for the year (1)

Award winning products in the past (1)